Metronidazole
- Generic Name
- Metronidazole
- Brand Names
- Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
- Drug Type
- Small Molecule
- Chemical Formula
- C6H9N3O3
- CAS Number
- 443-48-1
- Unique Ingredient Identifier
- 140QMO216E
- Background
Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it ...
- Indication
Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, t...
- Associated Conditions
- Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
- Associated Therapies
- -
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
- Conditions
- Interventions
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2019-05-13
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 390
- Registration Number
- NCT02159976
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
- Conditions
- Interventions
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Emory University
- Target Recruit Count
- 33
- Registration Number
- NCT02154061
- Locations
- 🇺🇸
Emory Vaccine Center, Atlanta, Georgia, United States
Impact of Oral Antibiotic Treatment on C. Difficile
- Conditions
- Interventions
- First Posted Date
- 2014-02-06
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Duke University
- Target Recruit Count
- 33
- Registration Number
- NCT02057198
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis
- Conditions
- Interventions
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 32
- Registration Number
- NCT02042287
- Locations
- 🇨🇭
Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern, Berne, Switzerland
The Amputation Surgical Site Infection Trial (ASSIT)
- Conditions
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- Hull University Teaching Hospitals NHS Trust
- Target Recruit Count
- 160
- Registration Number
- NCT02018094
- Locations
- 🇬🇧
Hull Royal Infirmary, Hull, United Kingdom
15-day Sequential Therapy for Helicobacter Pylori Infection in Korea
- Conditions
- Interventions
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 287
- Registration Number
- NCT01887249
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Bundang-gu, Seongnam, Gyeonggi-do, Korea, Republic of
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
- Conditions
- Interventions
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- Minia University
- Target Recruit Count
- 90
- Registration Number
- NCT01841411
- Locations
- 🇪🇬
Minia university hospital for gynecology and obstetrics, Minia, Egypt
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
- Conditions
- Interventions
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2013-08-28
- Target Recruit Count
- 1303
- Registration Number
- NCT01799356
- Locations
- 🇹🇷
T.C.S.B Mardin Women and Children Hospital, Mardin, Turkey
🇹🇷T.C.S.B. İstanbul Training Research Hospital, Samatya, Fatih, Turkey
🇹🇷T.C.S.B. Kanuni Sultan Suleyman Training Hospital, İstanbul, Kucukcekmece, Turkey
Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
- Conditions
- Interventions
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Seoul National University Bundang Hospital
- Target Recruit Count
- 648
- Registration Number
- NCT01792700
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
GoldenCareTM for the Treatment of Bacterial Vaginosis
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2015-02-03
- Lead Sponsor
- CDA Research Group, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01762670
- Locations
- 🇺🇸
Harper University Hospital Department of Infectious Diseases, Detroit, Michigan, United States
🇺🇸Temple University Hospital Department of OB/GYN, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.